HALO•benzinga•
Halozyme Therapeutics Q3 2024 Adj. EPS $1.27 Beats $0.98 Estimate, Sales $290.084M Beat $251.059M Estimate
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on October 31, 2024 by benzinga